Home LiteratureArticle Details
PMID: 2903210 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

The Journal of experimental medicine ·Vol. 168 ·No. 5 ·1988-11-01 ·Pages 1649-58

Granelli-Piperno A

Abstract

RNA-RNA in situ hybridization was used to study the frequency of cells producing mRNA for IL-2 and IL-2-R in T lymphocytes stimulated by either of three mitogens: anti-CD3, anti-CD28, or PHA. Both CD4+ and CD8+ T cells expressed transcripts for IL-2 and the low-affinity IL-2-R when stimulated with these mitogens plus PMA. IL-2 transcripts peaked at 8-16 h, and IL-2-R at 24-40 h. Cyclosporin A (CSA) inhibited the synthesis of IL-2, but not IL-2-R mRNA, after stimulation by PHA or anti-CD3. However, higher concentrations of CSA were necessary to achieve 50-70% inhibition after stimulation with anti-CD28. At optimal points 12-22% of CD4+ and 5-13% of CD8+ cells expressed IL-2 mRNA, while 30-50% of cells of both subsets had IL-2-R mRNA. The IL-2 grain counts, which relate to the level of mRNA/cell, were higher in the CD4+ subset but could be increased several fold in the CD8+ subset in the presence of adherent accessory cells. The use of PMA as an accessory stimulus, in addition to adherent cells, greatly increased the frequency of lymphocytes with IL-2 mRNA and the amount of IL-2 activity in the culture medium, but the proliferative response was not significantly boosted. These observations indicate at the single cell level that many CD4+ or CD8+ lymphocytes can make IL-2 mRNA, and that the induction of IL-2 with several stimuli is reduced by CSA and enhanced by PMA.

MeSH Terms
Antibodies, Monoclonal/immunology Antigen-Antibody Reactions CD4-Positive T-Lymphocytes/physiology Cyclosporins/pharmacology Gene Expression Regulation/drug effects Humans In Vitro Techniques Interleukin-2/genetics Lymphocyte Activation/drug effects Nucleic Acid Hybridization RNA, Messenger/genetics Receptors, Interleukin-2/genetics T-Lymphocytes/drug effects,physiology Time Factors
Chemicals
Antibodies, Monoclonal Cyclosporins Interleukin-2 RNA, Messenger Receptors, Interleukin-2
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Granelli-Piperno A
Rockefeller University, New York, New York 10021.
References (10)
10 references, click to expand
  1. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
    J Immunol. 1981 Apr;126(4):1393-7 PMID: 6970774
  2. Serological visualization of interleukin 2.
    Science. 1983 Jun 10;220(4602):1188-90 PMID: 6344215
  3. Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells.
    Proc Natl Acad Sci U S A. 1984 Apr;81(8):2543-7 PMID: 6201860
  4. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
    Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214-8 PMID: 6332315
  5. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
    Mol Cell Biol. 1987 Dec;7(12):4472-81 PMID: 2830495
  6. Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes.
    Eur J Immunol. 1985 Dec;15(12):1164-8 PMID: 3936719
  7. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.
    J Exp Med. 1986 Apr 1;163(4):922-37 PMID: 2419474
  8. Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes.
    Mol Immunol. 1987 May;24(5):409-19 PMID: 3116404
  9. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
    Proc Natl Acad Sci U S A. 1987 Dec;84(23):8573-7 PMID: 2825196
  10. Molecular cloning of cDNA encoding human interleukin-2 receptor.
    Nature. 1984 Oct 18-24;311(5987):631-5 PMID: 6090949
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1988-11-01
Pages
1649-58
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189101
Subset
IM
Grants
NIGMS NIH HHS · GM-37643 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]